NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · page 11 of 30
Study design timeline included; statistical significance noted for treatment groups.
Regulatory filing · appendix_data · analyze_data · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
chart 4/4 diagram 1/1 list 1/1 source-note 1/1 title 1/1
Components 8
bar-vertical bar-vertical bar-vertical bar-vertical timeline bullet source-note headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.